VAR2Pharmaceuticals receives a 7 million DKK grant from the Danish Innovation Foundation for ”Targeting cancer using a malaria derived protein drug conjugate”.
Our website only uses strictly necessary cookies. Please consult our Privacy Policy for additional information on how we process your data.